FR2307270A1 - Procede de determination quantitative d'une substance antigene et ensemble de diagnostic destine a la mise en oeuvre de ce procede - Google Patents

Procede de determination quantitative d'une substance antigene et ensemble de diagnostic destine a la mise en oeuvre de ce procede

Info

Publication number
FR2307270A1
FR2307270A1 FR7610417A FR7610417A FR2307270A1 FR 2307270 A1 FR2307270 A1 FR 2307270A1 FR 7610417 A FR7610417 A FR 7610417A FR 7610417 A FR7610417 A FR 7610417A FR 2307270 A1 FR2307270 A1 FR 2307270A1
Authority
FR
France
Prior art keywords
implementation
procedure
quantitative determination
antigen substance
diagnosis set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7610417A
Other languages
English (en)
Other versions
FR2307270B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FR2307270A1 publication Critical patent/FR2307270A1/fr
Application granted granted Critical
Publication of FR2307270B1 publication Critical patent/FR2307270B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Plasma & Fusion (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
FR7610417A 1975-04-10 1976-04-09 Procede de determination quantitative d'une substance antigene et ensemble de diagnostic destine a la mise en oeuvre de ce procede Granted FR2307270A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50042803A JPS605899B2 (ja) 1975-04-10 1975-04-10 免疫化学的定量法

Publications (2)

Publication Number Publication Date
FR2307270A1 true FR2307270A1 (fr) 1976-11-05
FR2307270B1 FR2307270B1 (fr) 1979-07-20

Family

ID=12646111

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7610417A Granted FR2307270A1 (fr) 1975-04-10 1976-04-09 Procede de determination quantitative d'une substance antigene et ensemble de diagnostic destine a la mise en oeuvre de ce procede

Country Status (6)

Country Link
US (1) US4091089A (fr)
JP (1) JPS605899B2 (fr)
DE (1) DE2615092C2 (fr)
FR (1) FR2307270A1 (fr)
GB (1) GB1508104A (fr)
SE (1) SE7604242L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410278A1 (fr) * 1977-11-25 1979-06-22 Int Diagnostic Tech Methode d'analyse par immunofluorescence

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178359A (en) * 1976-10-12 1979-12-11 Hoffmann-La Roche Inc. Immunoassay method
US4184849A (en) * 1977-12-05 1980-01-22 Technicon Instruments Corporation Mixed agglutination
US4163779A (en) * 1978-01-09 1979-08-07 International Diagnostic Technology, Inc. Test for quantitation of immunoglobulin and identification of abnormal immunoglobulin
JPS57501147A (fr) * 1980-07-16 1982-07-01
DE3212658C3 (de) * 1982-04-05 1993-08-19 American Hospital Supply Corp Verfahren zur antigen-bestimmung
US4459361A (en) * 1982-06-04 1984-07-10 Angenics, Inc. Ligand assay with one or two particulate reagents and filter
JPS60188846A (ja) * 1984-03-08 1985-09-26 Hitachi Ltd 自動分析方法
US4925788A (en) * 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
FR2665378B1 (fr) * 1990-08-03 1992-10-09 Guigan Jean Dispositif pour separer par centrifugation deux phases d'un echantillon d'un liquide heterogene, utilisable notamment pour la separation du plasma du sang total.
US5679309A (en) * 1995-12-14 1997-10-21 Beckman Instruments, Inc. Automated random access analyzer
WO2002039114A2 (fr) * 2000-11-13 2002-05-16 Sigma-Aldrich Co. Dosage, reatifs et necessaires destines a detecter ou determiner la concentration des analytes
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
CN1307422C (zh) * 2005-01-31 2007-03-28 上海市血液中心 一种质控品稀释液及其形成的质控品
CN104407159B (zh) * 2014-12-15 2016-03-02 山东博科生物产业有限公司 一种免疫球蛋白IgM免疫比浊法检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3284434A (en) * 1960-08-29 1966-11-08 Univ Kansas State Protein isolation and preparations
US3901654A (en) * 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410278A1 (fr) * 1977-11-25 1979-06-22 Int Diagnostic Tech Methode d'analyse par immunofluorescence

Also Published As

Publication number Publication date
DE2615092A1 (de) 1976-10-14
GB1508104A (en) 1978-04-19
SE7604242L (sv) 1976-10-11
JPS605899B2 (ja) 1985-02-14
JPS51118826A (en) 1976-10-19
FR2307270B1 (fr) 1979-07-20
DE2615092C2 (de) 1985-02-21
US4091089A (en) 1978-05-23

Similar Documents

Publication Publication Date Title
FR2307270A1 (fr) Procede de determination quantitative d'une substance antigene et ensemble de diagnostic destine a la mise en oeuvre de ce procede
AT347601B (de) Verfahren und diagnostisches hilfsmittel zur quantitativen immunochemischen pruefung von antigenen
DE3586440T2 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
JPS5283933A (en) Serum physiological method for detecting presence of nigeria gonoroe antigen
IT1069829B (it) Dispositivo e procediemnto per l esame dell andamento di reazioni biochimiche
BE863278A (nl) Werkwijze voor de bereiding van een intraveneus toedienbaar serumeiwitpreparaat
IT1037160B (it) Apparecchio per la misura di reazioni antigene anticorpo
BE863810A (fr) Procede de preparation d'un antigene et d'un anticorps
JPS5480411A (en) Detecting of generation of antigen antibody reaction
AR240366A1 (es) Pano para la recoleccion de especimenes para la deteccion de sangre oculta.
IT1025596B (it) Mezzo diagnostico per il controllo della coagulabilita delsangue processo per la sua preparazione e stabilizzante per questo mezzo
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
IT1086033B (it) Mezzo per eiliminare intorbidamenti nel siero e processo per la sua preparazione
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
BE881406A (fr) Procede d'identification d'une phase d'ovulation au cours du cycle menstruel
BE836553A (fr) Procede de recuperation des elements de catalyseurs comprenant un support alumineux du platine et de l'iridium
FR2522490B1 (fr) Appareil pour diagnostic par ultrasons
DE69032112D1 (de) Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
IL47664A0 (en) Radioimmune assay method for detection of gonorrhea antibodies
ATE9846T1 (de) Radioimmunoassay fuer migration-inhibitionsfaktor.
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
IT8423926A0 (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
FR2306445A2 (fr) Procede de tomographie et dispositif de mise en oeuvre de ce procede
IT1063099B (it) Mezzo diagnostico per l identificazione di urobilinogeno
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet

Legal Events

Date Code Title Description
ST Notification of lapse